NEW YORK, Sept. 18, 2024 /PRNewswire/ — Report on how AI is redefining market landscape- The global amniotic membrane market size is estimated to grow by USD 2.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 15.19% during the forecast period. Extensive use of amniotic membrane transplantation in ophthalmic surgeries is driving market growth, with a trend towards growing reimbursement coverage for new products. However, limited supply of amniotic membranes poses a challenge. Key market players include Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc..
Technavio has announced its latest market research report titled Global amniotic membrane market 2024-2028 AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Forecast period 2024-2028 Base Year 2023 Historic Data 2018 – 2022 Segment Covered End-user (Hospitals, Ambulatory surgical centers, Specialty clinics, and Research and academic institutes), Type (Cryopreserved amniotic membrane and Dehydrated amniotic membrane), and Geography (North America, Europe, Asia, and Rest of World (ROW)) Region Covered North America, Europe, Asia, and Rest of World (ROW) Key companies profiled Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc.
A. The Rise of Affordable Eye Care
B. Amniotic Membranes:
These factors have led to a rise in demand for cost-effective solutions, driving the growth of the amniotic membrane market. The market is also experiencing growth due to the rising prevalence of ophthalmic conditions, particularly in developing countries. This trend is attributed to factors such as aging populations, increased awareness of eye health, and the rising availability of affordable healthcare.
The Amniotic Membrane market is experiencing significant growth, particularly in the dressing segment for surgical subspecialties. This trend is driven by the increasing demand for tissue-based products in transplant procedures and the unmet healthcare needs in various sectors. Amniotic membranes, derived from the Amnion, offer advanced technologies such as dehydrated amniotic membranes and cryopreserved segments, providing anti-inflammatory, anti-scarring, and antibacterial properties. Key applications include ophthalmology, with a focus on eye conditions like corneal ulcers and pterygium excisions. The market also caters to non-healing chronic wounds, burn injuries, and pressure ulcers. Amniotic membranes are used as surgical grafts and biological bandages in ophthalmology surgeries, cosmetic surgeries, and orthopedics surgeries. Donations from cesarean deliveries are a crucial source of amniotic membranes. Amniotic transplants are gaining popularity in regenerative medicine, with ASCs segment and hospital segment being major consumers. Specialty clinics and healthcare facilities are also adopting alternative and advanced technologies to meet the growing demand. The market for amniotic membranes continues to expand, addressing the needs in various medical treatments and healthcare facilities.
Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! Market Challenges The amniotic membrane market has experienced growing demand due to its increasing usage. However, vendors face challenges in meeting this demand as amniotic membranes can only be obtained during childbirth, making their availability and supply limited. This scarcity leads to increased prices and higher healthcare costs. Additionally, amniotic membranes can only be sourced from donors who have been serologically screened, reducing the number of available sources. Regulatory bodies require informed consent from donors, which can limit the availability of donors due to ethical concerns. To address the supply issue, end-users are exploring alternatives such as synthetic membranes manufactured from polymers. Manufacturers are developing pipeline products like 3D-printed membranes and electrospinning technology to create fully resorbable synthetic membranes, potentially reducing the reliance on naturally derived amniotic membranes and associated costs.
* **Growing Demand:** The global Amniotic Membrane Market is experiencing a surge in demand, driven by factors such as an aging population, rising prevalence of ocular diseases, and increasing awareness of wound healing therapies. * **Technological Advancements:** Technological advancements in amniotic membrane processing and manufacturing are contributing to the market’s growth. These advancements include the development of novel biocompatible materials and improved sterilization techniques.
Insights into how AI is reshaping industries and driving growth- Download a Sample Report Segment Overview This amniotic membrane market report extensively covers market segmentation by End-user 1.1 Hospitals 1.2 Ambulatory surgical centers 1.3 Specialty clinics 1.4 Research and academic institutes Type 2.1 Cryopreserved amniotic membrane 2.2 Dehydrated amniotic membrane Geography 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Hospitals- The amniotic membrane is a valuable biological material sourced from the innermost placenta layer. Hospitals utilize its unique properties, including anti-inflammatory and anti-microbial capabilities, for various medical applications. In ophthalmology, it serves as a graft for wound healing, reducing scarring, and treating ocular surface disorders during surgeries like corneal and conjunctival reconstruction. For chronic non-healing wounds, such as diabetic foot ulcers, venous leg ulcers, and burns, amniotic membranes act as biological dressings, creating a moist environment, relieving pain, and accelerating healing. In dermatology, they are used for skin conditions treatment, either topically or as grafts for wound healing, scar revision, and tissue regeneration. In gynecology and obstetrics, amniotic membranes can repair vaginal or cervical lacerations, promote post-surgical healing, and address conditions like intrauterine adhesions. The growing adoption of amniotic membranes in hospitals will fuel the global amniotic membrane market expansion during the forecast period.
These membranes, rich in growth factors and other bioactive molecules, offer a promising avenue for tissue regeneration and repair. The use of amniotic membranes in regenerative medicine is gaining traction, with researchers exploring their potential in treating a wide range of conditions, including burns, wounds, and even organ transplantation. Amniotic membranes are naturally derived from the placenta, making them a readily available and sustainable resource.
Market Research Overview Amniotic membranes, derived from the innermost layer of the placenta, have emerged as valuable medical treatments in various fields due to their unique properties. These membranes offer anti-inflammatory, anti-scarring, and antibacterial benefits, making them ideal for use in ocular diseases, burn injuries, and wound care. In ophthalmology, amniotic transplants are used in surgeries for conditions like dry eye disease, corneal ulcers, and pterygium excisions. In burn treatment, amniotic membranes aid in tissue regeneration and pain relief. Wound care biologics, including lyophilized amniotic membranes and amniotic allografts, are used for non-healing chronic wounds and surgical grafts. Amniotic membranes also find applications in cosmetic surgeries, orthopedics, and sports medicine. Medical advancements continue to explore the potential of amniotic membranes in regenerative medicines, drug development technology, and alternative and advanced technologies to address unmet healthcare needs. Amniotic membranes are obtained from donations and undergo processes like cryopreservation and lyophilization to ensure their availability for various surgical procedures and transplant procedures. The hospitals segment and specialty clinics are significant markets for amniotic membranes, with growing demand from healthcare facilities.
Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation End-user Hospitals Ambulatory Surgical Centers Specialty Clinics Research And Academic Institutes Type Cryopreserved Amniotic Membrane Dehydrated Amniotic Membrane Geography North America Europe Asia Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
Technavio is a global leader in market research and analysis, providing insights and intelligence on emerging technologies and industries. Technavio’s extensive report library, comprising over 17,000 reports and counting, offers a comprehensive understanding of various technologies and industries. The company boasts a team of over 500 specialized analysts who contribute to the creation of these reports.
